Evidence map›Paper›PMID 40151131›Full record

ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2025

Efficacy of Jiedu formula as adjuvant therapy for early recurrence of hepatocellular carcinoma after radical surgery: a propensity score matching study.

Feng Qiuting, H U Jiajia, Y U Song, Zhu Huirong, Cheng Simo, Zhai Xiaofeng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feng QiutingSchool of Traditional Chinese Medicine, Naval Medical University, Shanghai 200433, China.
H U JiajiaSchool of Traditional Chinese Medicine, Naval Medical University, Shanghai 200433, China.
Y U SongSchool of Traditional Chinese Medicine, Naval Medical University, Shanghai 200433, China.
Zhu HuirongDepartment of Oncology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Cheng SimoSchool of Traditional Chinese Medicine, Naval Medical University, Shanghai 200433, China.
Zhai XiaofengSchool of Traditional Chinese Medicine, Naval Medical University, Shanghai 200433, China.

Funding

Medical Innovation Research Project of Shanghai Science and Technology Commission: a Multicenter Prospective Randomized Controlled Study of "Arsenic Target" Combination Therapy for Unresectable Hepatocellular Carcinoma 22Y11921200Natural Science Foundation-funded Project: Mechanism of Action of Detoxification Formula to Inhibit Hypoxia-Inducible Factor 1 Alpha-Exosomal MicroRNA-130b-3p-Sterile Alpha Motif Domain-Containing Protein 90-mediated Macrophage M2-type Polarisation to Improve the Immunosuppressive Microenvironment in Hepatocellular Carcinoma 82374540
6 · The paper itself

Abstract

objectiveTo investigate the clinical efficacy of using a Jiedu formula as an adjunctive therapy in patients with hepatocellular carcinoma (HCC) after hepatectomy.

methodsIn total, 354 patients were included in this study. All patients were categorized into the traditional herbal medicine (THM) group (

resultsThe one, two, three, and five-year RFS rates of the THM and nTHM groups were 76.4%

conclusionIn this study, THM was found to be an effective agent for adjuvant therapy for HCC to prevent early recurrence of HCC after hepatic resection.

Indexed as

Carcinoma, HepatocellularDrugs, Chinese HerbalLiver NeoplasmsNeoplasm Recurrence, LocalAdultAgedFemaleHepatectomyHumansMaleMiddle AgedPropensity ScoreDrugs, Chinese Herbalcarcinoma, hepatocellularchemotherapy, adjuvantJiedu formulaliver resectionpropensity score

Identifiers

PMID40151131
PMCPMC11955764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.